These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6896294)

  • 1. Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study.
    Amrein PC; Coleman M; Richards F; Poulin RF; Bernhardt B; Ginsberg SJ; Green MR; Morrison A; Cortes E; Kiang D; Weinberg V; Wood WC
    Cancer Treat Rep; 1982 May; 66(5):1211-3. PubMed ID: 6896294
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
    Currie VE; Howard J; Wittes R
    Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.
    Tannir N; Spitzer G; Schell F; Legha S; Zander A; Blumenschein G
    Cancer Treat Rep; 1983 Jun; 67(6):599-600. PubMed ID: 6344995
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancer.
    Legha SS; Blumenschein GR; Buzdar AU; Hortobagyi GN; Bodey GP
    Cancer Treat Rep; 1979; 63(11-12):1961-4. PubMed ID: 526929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
    Natale RB; Yagoda A; Blumenreich MS; Watson RC
    Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M-AMSA in disseminated prostatic carcinoma: a phase II study.
    Drelichman A; Decker DA; Al-Sarraf M; Dhabuwala CB
    Cancer Treat Rep; 1982 Nov; 66(11):1993-4. PubMed ID: 6897206
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of AMSA in patients with advanced ovarian cancer.
    Kearsley JH; Coates AS; Fox RM; Tattersall MH; Page J; Levi JA
    Cancer Treat Rep; 1982 May; 66(5):1242-3. PubMed ID: 6896295
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
    Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
    Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of AMSA in refractory breast cancer.
    De Lena M; Rossi A; Bonadonna G
    Cancer Treat Rep; 1982 Feb; 66(2):403-4. PubMed ID: 6895717
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of AMSA in patients with metastatic malignant melanoma.
    Houghton AM; Camacho F; Wittes R; Young CW
    Cancer Treat Rep; 1981; 65(1-2):170-1. PubMed ID: 6894401
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II evaluation of AMSA in patients with metastatic lung cancer.
    Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of AMSA in previously treated patients with stage III and IV ovarian cancer.
    Schneider RJ; Woodcock TM; Howerd J; Ochoa M
    Cancer Treat Rep; 1982 Jul; 66(7):1589-90. PubMed ID: 6896470
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.
    Ahmann FR; Meyskens FL; Jones SE; Bukowski RM; Saiers JH; Ryan DH; Costanzi J; Vaughn CB; Coltman CA
    Cancer Treat Rep; 1983; 67(7-8):697-700. PubMed ID: 6688199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
    Van Echo DA; Markus S; Aisner J; Wiernik PH
    Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ
    Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase I-II studies of a new antineoplastic agent, 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA)].
    Horikoshi N; Ogawa M; Inagaki J; Ezaki K; Inoue K; Okabe K; Nagata T; Aiba K; Domyo M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):244-9. PubMed ID: 6897858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase II study.
    Amrein PC; Coleman M; Richards F; Bhardwaj S; Kennedy BJ; Haurani FI; Frelick RW; Pastmantier MW; Herschkopf R
    Cancer Treat Rep; 1984 Nov; 68(11):1397-8. PubMed ID: 6548660
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.
    Bukowski RM; Legha S; Saiki J; Eyre HJ; O'Bryan R
    Cancer Treat Rep; 1982 Aug; 66(8):1651-2. PubMed ID: 6286120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny N; Lynch G; Wookcock T
    Cancer Treat Rep; 1980; 64(10-11):1149-50. PubMed ID: 6893951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.